Clinical outcomes after viraemia among people receiving dolutegravir versus efavirenz-based first-line antiretroviral therapy in South Africa https://www.medrxiv.org/content/10.1101/2023.08.15.23293965
Clinical outcomes after viraemia among people receiving dolutegravir versus efavirenz-based first-line antiretroviral therapy in South Africa https://www.medrxiv.org/content/10.1101/2023.08.15.23293965